Literature DB >> 23760743

Association of IL-6 G-174C polymorphism with bone mineral density.

Yuanyuan Ni1, Hua Li, Yang Zhang, Hao Zhang, Yongchu Pan, Junqing Ma, Lin Wang.   

Abstract

Functional polymorphisms in the promoter region of interleukin-6 (IL-6) are known to be involved in bone mineral density (BMD) and the development of osteoporosis, but the reported results have been inconsistent. Using the meta-analysis approach, the present study is designed to provide a relatively comprehensive picture of the relationship between bone mineral density (BMD) or osteoporosis and polymorphisms in the promoter region of IL-6 (rs1800795 and rs1800796). The difference of bone mineral density (BMD) values between genotypes was examined by mean difference and 95 % confidence intervals (CIs). Association between IL-6 polymorphism and clinical osteoporosis was evaluated by pooled odds ratios (ORs) and 95 % CIs. A total of 13 articles with 11,499 subjects were included in the present study. For -174 (rs1800795), we found that individuals with the G/G genotype had a significantly lower BMD value than those with C/C genotype at femoral neck (0.02 g/cm(2), 95 % CI 0.00-0.03) (p = 0.04) and distal radius (0.01 g/cm(2), 95 %CI 0.01-0.01) (p < 0.0001). However, we did not find a statistically significant difference of BMD at the spine. When analysis was limited to postmenopausal women, similar results were obtained. We further found that the C/C genotype was associated with a reduced risk of osteoporosis compared to G/G genotype, and the pooled OR was 0.72 (95 % CI 0.54-0.95, p = 0.02). In addition, a significant relationship was found between G-634C (rs1800796) polymorphism and distal radius BMD (CC vs. GG: 0.02 g/cm(2), 95 % CI 0.01-0.03; GC vs. GG: 0.02 g/cm(2), 95 % CI 0.00-0.03) in the Asian population. These findings suggest that the CC genotype of IL-6 G-174C polymorphism may be associated with high BMD at femoral neck and distal radius and decreased risk of osteoporosis in the Caucasian population whereas G-634C polymorphism was associated with distal radius BMD in Asians.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23760743     DOI: 10.1007/s00774-013-0477-2

Source DB:  PubMed          Journal:  J Bone Miner Metab        ISSN: 0914-8779            Impact factor:   2.626


  45 in total

1.  A meta-analysis of interleukin-6 promoter polymorphisms on risk of hip and knee osteoarthritis.

Authors:  A M Valdes; N K Arden; A Tamm; K Kisand; S Doherty; E Pola; C Cooper; A Tamm; K R Muir; I Kerna; D Hart; F O'Neil; W Zhang; T D Spector; R A Maciewicz; M Doherty
Journal:  Osteoarthritis Cartilage       Date:  2010-02-06       Impact factor: 6.576

2.  Polymorphisms of the interleukin-6 gene are associated with bone mineral density.

Authors:  R E Murray; F McGuigan; S F Grant; D M Reid; S H Ralston
Journal:  Bone       Date:  1997-07       Impact factor: 4.398

3.  Association tests of interleukin-6 (IL-6) and type II tumor necrosis factor receptor (TNFR2) genes with bone mineral density in Caucasians using a re-sampling approach.

Authors:  Peng Xiao; Peng-Yuan Liu; Yan Lu; Yan-Fang Guo; Dong-Hai Xiong; Li-Hua Li; Robert R Recker; Hong-Wen Deng
Journal:  Hum Genet       Date:  2005-05-20       Impact factor: 4.132

4.  Serum interleukin 6 is a major predictor of bone loss in women specific to the first decade past menopause.

Authors:  C Scheidt-Nave; H Bismar; G Leidig-Bruckner; H Woitge; M J Seibel; R Ziegler; J Pfeilschifter
Journal:  J Clin Endocrinol Metab       Date:  2001-05       Impact factor: 5.958

5.  Association of interleukin-6 gene polymorphisms with bone mineral density in Mexican women.

Authors:  Jonathan J Magaña; Rocío Gómez; Bulmaro Cisneros; Leonora Casas; Margarita Valdés-Flores
Journal:  Arch Med Res       Date:  2008-08       Impact factor: 2.235

6.  Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: The Chingford Study.

Authors:  Gregory Livshits; Guangju Zhai; Deborah J Hart; Bernet S Kato; Huizhong Wang; Frances M K Williams; Tim D Spector
Journal:  Arthritis Rheum       Date:  2009-07

7.  Prediction of bone density from vitamin D receptor alleles.

Authors:  N A Morrison; J C Qi; A Tokita; P J Kelly; L Crofts; T V Nguyen; P N Sambrook; J A Eisman
Journal:  Nature       Date:  1994-01-20       Impact factor: 49.962

8.  Association of the G-174C variant in the interleukin-6 promoter region with bone loss and fracture risk in older women.

Authors:  Susan P Moffett; Joseph M Zmuda; Jane A Cauley; Katie L Stone; Michael C Nevitt; Kristine E Ensrud; Teresa A Hillier; Marc C Hochberg; Geoff Joslyn; Phillip Morin; Steven R Cummings
Journal:  J Bone Miner Res       Date:  2004-07-12       Impact factor: 6.741

9.  The effect of novel polymorphisms in the interleukin-6 (IL-6) gene on IL-6 transcription and plasma IL-6 levels, and an association with systemic-onset juvenile chronic arthritis.

Authors:  D Fishman; G Faulds; R Jeffery; V Mohamed-Ali; J S Yudkin; S Humphries; P Woo
Journal:  J Clin Invest       Date:  1998-10-01       Impact factor: 14.808

Review 10.  New insights into the cellular, biochemical, and molecular basis of postmenopausal and senile osteoporosis: roles of IL-6 and gp130.

Authors:  S C Manolagas; T Bellido; R L Jilka
Journal:  Int J Immunopharmacol       Date:  1995-02
View more
  3 in total

1.  No Interaction Effect between Interleukin-6 Polymorphisms and Acid Ash Diet with Bone Resorption Marker in Postmenopausal Women.

Authors:  Sook Yee Lim; Yoke Mun Chan; Vasudevan Ramachandran; Zalilah Mohd Shariff; Yit Siew Chin; Manohar Arumugam
Journal:  Int J Environ Res Public Health       Date:  2021-01-19       Impact factor: 3.390

2.  Association of IL-6 174G/C (rs1800795) and 572C/G (rs1800796) polymorphisms with risk of osteoporosis: a meta-analysis.

Authors:  Bin Chen; Hong-Zhuo Li
Journal:  BMC Musculoskelet Disord       Date:  2020-05-28       Impact factor: 2.362

Review 3.  Cytokines in Inflammatory Disease.

Authors:  Shinwan Kany; Jan Tilmann Vollrath; Borna Relja
Journal:  Int J Mol Sci       Date:  2019-11-28       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.